Center for Translational Biomedical Research

Zhang awarded $500K AHA grant

Posted on Wednesday, May 9th, 2018 by Sangeetha Shivaji under News.

Repost from UNCG Now

UNC Greensboro’s Dr. Qibin Zhang, associate professor of chemistry and biochemistry and co-director for the Center for Translational Biomedical Research, has been awarded $496,303 to study biomarkers of cardiovascular complications in Type 1 diabetes. This is the first-ever grant awarded by the American Heart Association (AHA) in Guilford County, and the association’s first for a UNCG researcher.

The Collaborative Sciences Award will enable Zhang and his team, including collaborators from the University of Colorado School of Medicine, to address a critical medical condition in the United States: cardiovascular disease. More than 2,150 Americans die from cardiovascular disease each day – one every 40 seconds. Cardiovascular disease is the leading cause of death in people with Type 1 diabetes, Zhang’s focus, and diabetes accounts for a majority of cardiovascular disease incidence in the United States. However, only about half of the risk can be explained by known factors.

“At UNCG, we have long been recognized as a higher-research activity university by the Carnegie Foundation,” said Dr. Terri Shelton, vice chancellor for research and engagement. “This award recognizes our expertise in developing and applying new knowledge that addresses a major health issue, not only in our community, but across the nation. We are honored to receive such generous funding from AHA; the fact that the university is the first to be awarded in Guilford County makes the grant even more special. This is ground-breaking, life-saving work.”

Since 1949, the AHA has invested more than $4 billion in research to increase knowledge about cardiovascular disease and stroke. Locally, the organization has provided $1.2 million in research funding in the Triad this year, with $18.6 million in research funding in North Carolina currently. AHA research programs have contributed to many important scientific advances, including CPR, pacemakers, drug-eluting stents, clot-busting medicines and cholesterol inhibitors, among others.